key: cord-1018862-1wi140w1
authors: Borges, Vítor; Sousa, Carlos; Menezes, Luís; Gonçalves, António Maia; Picão, Miguel; Almeida, José Pedro; Vieita, Margarida; Santos, Rafael; Silva, Ana Rita; Costa, Mariana; Carneiro, Luís; Casaca, Pedro; Pinto-Leite, Pedro; Peralta-Santos, André; Isidro, Joana; Duarte, Sílvia; Vieira, Luís; Guiomar, Raquel; Silva, Susana; Nunes, Baltazar; Gomes, João P
title: Tracking SARS-CoV-2 lineage B.1.1.7 dissemination: insights from nationwide spike gene target failure (SGTF) and spike gene late detection (SGTL) data, Portugal, week 49 2020 to week 3 2021
date: 2021-03-11
journal: Euro Surveill
DOI: 10.2807/1560-7917.es.2021.26.10.2100130
sha: 1ccc9f0f9528270c970a99dba7ad7e2b417e9384
doc_id: 1018862
cord_uid: 1wi140w1

We show that the SARS-CoV-2 B.1.1.7 lineage is highly disseminated in Portugal, with the odds of B.1.1.7 proportion increasing at an estimated 89% (95% confidence interval: 83–95%) per week until week 3 2021. RT-PCR spike gene target late detection (SGTL) can constitute a useful surrogate to track B.1.1.7 spread, besides the spike gene target failure (SGTF) proxy. SGTL/SGTF samples were associated with statistically significant higher viral loads, but not with substantial shift in age distribution compared to non-SGTF/SGTL cases.

and MagMAX™ Viral/Pathogen II Nucleic Acid Isolation Kit (Thermo Scientific™) according to manufacturer instructions for a 200 µL sample input. The amplification was performed on the QuantStudio™ 5 Real-Time PCR System (Applied Biosystems™). Results interpretation and data transfer to LIS (includes Cycle thresholds, Ct) performed in the COVID-19 Interpretative software (Thermo Scientific™) under HL7 communication protocol.

Cycle threshold (Ct) data obtained for the three SARS-CoV-2 gene targets (ORF1ab, N and S) was compiled for all positive tests (n = 36,651), which were classified as follows: i) "S gene target failure (SGTF), i.e., positive test with non-detectable Spike (S) gene and <=30 Ct for N and ORF1ab targets; ii) "S gene target late detection (SGTL)", i.e., positive test having Ct values for S gene >5 units higher than the maximum Ct value obtained for the other two targets (N and ORF1ab) of the assay (as for SGTF group, SGTL exclusively includes positive samples with <=30 Ct for N and ORF1ab targets); or iii) "non-SGTF/SGTL", i.e., positive test that was neither SGTF nor SGTL, regardless of the Ct range.

In order to assess the proportion of SGTF/SGTL positive samples that are B.1.1.7, 86 SGTF and 12 SGTL country spread samples were subjected to SARS-CoV-2 genome sequencing at Portuguese National Institute of Health (INSA) following an amplicon-based whole-genome amplification strategy using tiled, multiplexed primers 1 Results are expressed as odds ratio (estimated increase in the odds of the outcome per unit of time), calculated as follows: frequency of "SGTF/SGTL" divided by (1 -frequency non-"SGTF/SGTL").

In Kruskal-Walls one-way ANOVA non-parametric test was used to assess the existence of statistically significant differences in Ct values between groups. Differences in Ct values for each pair of groups were assessed using the Dunn test adjusted for multiple comparison tests with Bonferroni correction.

The age (years) distribution of was plotted by age group for both SGTF/SGTL and non-SGTF/SGTL-associated individuals. As the SGTF/SGTL group exclusively includes positive samples with <=30 Ct for N and ORF1ab targets (see definition above), only non-SGTF/SGTL positive samples having both N and ORF1a positive signals and Ct values <=30 were used in this comparison. In addition, violin and box-plot were built for each group and statistical difference was assessed using the Mann-Whitney-Wilcoxon test.

Multiplex PCR method for MinION and Illumina sequencing of Zika and other virus genomes directly from clinical samples

Massive dissemination of a SARS-CoV-2 Spike Y839 variant in Portugal

INSaFLU: an automated open web-based bioinformatics suite "from-reads" for influenza whole-genome-sequencingbased surveillance

A new coronavirus associated with human respiratory disease in China

A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology

Supplementary Figure S1. Geographical distribution of Unilabs sample collection points where SGTF and SGTL were detected between week